Revance Therapeutics Inc (NASDAQ:RVNC)

22.46
Delayed Data
As of Aug 12
 +1.02 / +4.76%
Today’s Change
11.27
Today|||52-Week Range
30.00
+37.62%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Foley Mark J
President & Chief Executive Officer
Sale10/13/202142,096$23.08$971.6K-2.56%
Foley Mark J
Chief Executive Officer
Buy11/29/202140,000$12.90$516.0K+80.50%
Rankin Aubrey
Buy12/03/202130,000$14.43$432.9K+54.04%
Rankin Aubrey
Sale8/16/20219,364$26.34$246.6K-15.26%
Rankin Aubrey
Sale8/15/20214,949$26.02$128.8K-15.26%
Russell Angus C
Director
Buy12/13/20216,400$15.74$100.7K+44.63%
Moxie Dwight
Secretary, Senior Vice President & General Counsel
Sale9/27/20211,675$30.00$50.3K-24.17%
Schilke Tobin C
Chief Financial Officer
Sale12/15/20211,556$15.92$24.8K+41.27%
Sjuts Dustin S
President
Gift6/30/20221,000$11.75$11.8K+62.74%
Foley Mark J
Chief Executive Officer
Gift6/30/20221,000$11.75$11.8K+62.74%
Page of 2